Primary Care Clinics in Greenville, AL Accepting Medicare
10 Primary Care Clinics found. Showing 1 - 10
 Rmcca Clinic B, Llc Family Medicine Medicare: Medicare Enrolled Practice Location: 45 Medical Arts Ct Ste 3, Greenville, AL 36037 Phone: 334-382-2681 |
American Family Care, Llc General Practice Medicare: Not Enrolled in Medicare Practice Location: 101 Paul Stabler Drive, Greenville, AL 36037 Phone: 334-382-0734 Fax: 334-382-0795 |
Regional Medical Center Clinics Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 300 N College Street, Greenville, AL 36037 Phone: 334-382-2681 Fax: 334-383-9884 |
Lv Stabler Primary Care Llc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 45 Medical Arts Ct Ste 2, Greenville, AL 36037 Phone: 334-382-1632 |
Regional Medical Center Clinics Internal Medicine Medicare: Medicare Enrolled Practice Location: 45 Medical Arts Court Suite 1, Greenville, AL 36037 Phone: 334-382-5564 |
Stabler Clinic, P.c. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 N College St, Greenville, AL 36037 Phone: 334-382-2681 Fax: 334-383-9541 |
Pro-med, P.c. Family Medicine Medicare: Medicare Enrolled Practice Location: 302 Paul Stabler Drive, Greenville, AL 36037 Phone: 334-382-0530 Fax: 334-382-0498 |
Stephens Chiropractic Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 202 Church St, Greenville, AL 36037 Phone: 334-382-6343 Fax: 334-382-7907 |
Regional Medical Center Clinics Family Medicine Medicare: Medicare Enrolled Practice Location: 300 N College St, Greenville, AL 36037 Phone: 334-382-2681 |
Norman F. Mcgowin Iii Md Pc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 45 Medical Arts Court, Suite 4, Greenville, AL 36037 Phone: 334-382-6864 Fax: 334-382-6929 |
News Archive
Research findings could lead to new potential treatment for multiple sclerosis
Myelin, the fatty coating that protects neurons in the brain and spinal cord, is destroyed in diseases such as multiple sclerosis. Researchers have been striving to determine whether oligodendrocytes, the cells that produce myelin, can be stimulated to make new myelin. Using live imaging in zebrafish to track oligodendrocytes in real time, researchers reporting in the June 24 issue of the Cell Press journal Developmental Cell discovered that individual oligodendrocytes coat neurons with myelin for only five hours after they are born. If the findings hold true in humans, they could lead to new treatment strategies for multiple sclerosis.
A patient's tolerance for risky decisions can predict chances of opioid relapse
People in treatment for opioid addiction are more likely to relapse when they become more tolerant of risks, according to a study by Rutgers and other institutions. The findings can help clinicians better predict which patients are most vulnerable.
Why do men choose one prostate cancer treatment over another?
Men with prostate cancer generally make treatment decisions based on differences in the information they receive rather than their own preferences, according to a new review.
Durata completes target enrollment in dalbavancin Phase 3 trials for abSSSI
Durata Therapeutics today announced that it has completed its target enrollment for DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response"), one of two ongoing, global, Phase 3 clinical trials of Durata's lead product candidate, dalbavancin, under investigation for the treatment of acute bacterial skin and skin structure infections (abSSSI).
Obama thanks nurses for health law support, nurse practitioners push role
President Obama Wednesday thanked the American Nurses Association for supporting the health reform effort, The Associated Press reports. "Obama said nurses are the 'beating heart' of the health care system. … The Obama administration on Wednesday also announced new funding (Today's Daily Report includes summaries of coverage related to this announcement.) to help educate and train full-time nurses" (Simmons, 6/17).
› Verified 8 days ago